Everstar Asset Management’s AbbVie ABBV Stock Holding History

Everstar Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Buy	5,176 +303	+6%	+$65.2K	0.63%	39
2026 Q1	$1.06M	Buy	4,873 +128	+3%	+$28.4K	0.56%	60
2025 Q4	$1.08M	Buy	4,745 +73	+2%	+$16.6K	0.58%	48
2025 Q3	$1.08M	Buy	4,672 +356	+8%	+$72.5K	0.61%	42
2025 Q2	$801K	Buy	4,316 +1,639	+61%	+$305K	0.49%	59
2025 Q1	$561K	Sell	2,677 -51	-2%	-$9.91K	0.37%	85
2024 Q4	$485K	Buy	2,728 +444	+19%	+$81.6K	0.34%	78
2024 Q3	$451K	Buy	+2,284	New	+$426K	0.31%	97

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Everstar Asset Management's ABBV Position: Q2 2026 in Review

Everstar Asset Management increased its AbbVie (ABBV) stake by 6.2% in Q2 2026, buying an estimated $65.2K and bringing the position to 5,176 shares worth $1.3M. The position accounts for 0.63% of the portfolio, ranked #39.

Everstar Asset Management first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Everstar Asset Management held 5,176 shares of AbbVie worth $1.3M as of Q2 2026.
Everstar Asset Management bought 303 AbbVie shares in Q2 2026, an estimated $65.2K.
AbbVie made up 0.63% of Everstar Asset Management's portfolio in Q2 2026, its #39 holding.
Everstar Asset Management first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Everstar Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.